Board Member at Synlogic, Inc.
Ed Mathers has served as a member of our board of directors since February 2016. Mr. Mathers joined NEA as a Partner in August 2008 and is focused on biotechnology and specialty pharmaceuticals investments. He is a director of Liquidia Technologies, Ra Pharmaceuticals Nasdaq: RARX - Chairman), Rhythm Pharmaceuticals, Envisia Therapeutics, Synlogic, (Nasdaq: SYBX), Lumos Pharma, Amplyx Pharmaceuticals, Senti Biosciences, Inozyme, Reneo Pharma, Akouos, and Trevi Therapeutics. Previously he was a board member of Lumena (sold to Shire), Ziarco (sold to Novartis), Motus Therapeutics (sold to Allergan), Plexxikon (sold to Daiichi Sankyo), Intarcia, ...
Source: ObsEva SA on 04/27/2018
By accessing BoardEdge, you can view bios, network, connections and references of industry leading executives like Ed Mathers. More specifically, you'll be able to:
Access over 200,000 executive and board member profiles.
Example: Ed Mathers
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.
Thank you for your interest.